Jifu Medical
Specialized in the production, sales and service of high-end medical products for the digestive tract
About Jifu Medical
Established in 2011, Shenzhen Jifu Medical Technology Co., Ltd. is a specialized medical technology firm concentrating on high-end devices for the digestive tract. The company operates from its headquarters in Shenzhen's Nanshan District, a hub for high-tech enterprises in China, and manages a modern production facility in the Guangming District. This manufacturing site adheres to Good Manufacturing Practices (GMP) and is certified under the ISO 13485 quality management system.
The company's core business revolves around the development, manufacturing, sales, and service of its proprietary medical technologies. Jifu Medical primarily serves medical institutions, providing them with advanced tools for digestive health diagnostics. The business model is B2B, focusing on equipping medical practitioners with sophisticated examination technologies. The company has secured multiple rounds of funding, including a significant Series C round in September 2020, backed by investors such as Bojiang Capital, Greenwoods Investment, and EFung Capital, to fuel its growth and development.
Jifu Medical's flagship product is the "Dasheng" magnetically controlled capsule endoscopy system. This system offers a non-invasive method for examining the gastrointestinal tract; patients swallow a small capsule equipped with a camera, which clinicians can then navigate externally using magnetic controls to capture images of the stomach and intestines. This procedure presents an alternative to traditional, more invasive gastroscopy and colonoscopy. The Dasheng system has received Class III medical device registration from China's NMPA and CE certification in Europe, underscoring its adherence to safety and performance standards. The company has a robust R&D focus, resulting in over 100 national patents for its innovations.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Oct 2020 | $28M | $110M | Greenwoods Investment · Bojiang Capital Management Group | — |
| SERIES BEquity / VC | Jan 2019 | — | — | Dingxin Capital | ↗ |
Growth signals
Latest recorded traffic for Jifu Medical is 730 monthly website visits, up 37.7% over the last three months. Jifu Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Jifu Medical in the Shenzhen ecosystem
The Jifu Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- DCDingxin Capital
Proxima Ventures
Series B and later2 investors entered at this stage
Greenwoods Investment- BGBojiang Capital Management Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jifu Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jifu Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







